Effects of Postconditioning On Myocardial Reperfusion (POST)
This study has been completed.
Sponsor:
Samsung Medical Center
Information provided by (Responsible Party):
Hyeon-Cheol Gwon, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT00942500
First received: July 13, 2009
Last updated: October 31, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to investigate the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction.
| Condition | Intervention |
|---|---|
|
Myocardial Reperfusion Myocardial Infarction |
Procedure: Post-conditioning |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effects of Postconditioning On Myocardial Reperfusion in Patients With ST-segment Elevation Myocardial Infarction |
Resource links provided by NLM:
Further study details as provided by Samsung Medical Center:
Primary Outcome Measures:
- The dichotomous rate of complete ST-segment resolution (STR) [ Time Frame: at 30 minutes after final contrast injection ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Myocardial blush grade [ Time Frame: within 10 minutes after PCI ] [ Designated as safety issue: No ]
- Thrombolysis in Myocardial Infarction (TIMI) flow grade [ Time Frame: within 10 minutes after PCI ] [ Designated as safety issue: No ]
- Angiographic no-reflow [ Time Frame: during PCI ] [ Designated as safety issue: No ]
- All death [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: Yes ]
- Stent thrombosis [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: Yes ]
- Cardiac death [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: Yes ]
- Myocardial infarction [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: Yes ]
- Severe heart failure [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: No ]Severe heart failure was defined as heart failure with documented arterial partial pressure of oxygen less than 60 mmHg or with pulmonary edema documented radiographically or requiring intubation, 100% oxygen, or insertion of a mechanical support device.
- Target vessel revascularization (TVR) [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: No ]
- Composite of death, MI, severe heart failure, or stent thrombosis [ Time Frame: at 30 days and 1 year ] [ Designated as safety issue: Yes ]
| Enrollment: | 700 |
| Study Start Date: | July 2009 |
| Study Completion Date: | August 2012 |
| Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Post-conditioning |
Procedure: Post-conditioning
Coronary angiogram is performed to allow identification of the culprit coronary artery and to check no reperfusion before PCI (TIMI grade <2). Restoration of coronary blood flow can be achieved by thrombus aspiration, balloon angioplasty, direct stenting or together.In the postconditioning group, immediately after restoration (TIMI grade ≥2) of coronary flow (without regard to method of achieving restoration), angioplasty balloon will be positioned at the culprit lesion or stented segment and inflated 4 times for 1 minute with low-pressure (4 to 6 atm) inflations, each separated by 1 minute of reflow. When restoration of coronary flow is achieved by thrombus aspiration or balloon angioplasty and residual stenosis is remained ≥30%, stent will be deployed.
|
| No Intervention: Conventional primary PCI |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria General Inclusion Criteria
- Subject must be at least 18 years of age.
- Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving postconditioning and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure
Diagnosis of STEMI
- presence of chest pain for more than 30 minutes but less than 12 hours after symptom onset
- ST-segment elevation more than 1 mm in at least 2 contiguous leads
Angiographic Inclusion Criteria
- Target lesion(s) must be located in a native coronary artery
- Target lesion(s) must be amenable for percutaneous coronary intervention
- TIMI flow grade of infarct related arteries <2
General Exclusion Criteria
- Patients with hemodynamic instability or those with cardiogenic shock
- Target lesion is located in left main stem
- Rescue PCI after thrombolysis or facilitated PCI
- Non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment)
- Female of childbearing potential, unless a recent pregnancy test is negative, who possibly plan to become pregnant any time after enrollment into this study
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00942500
Locations
| Korea, Republic of | |
| Samsung Medical Center | |
| Seoul, Korea, Republic of, 135-710 | |
Sponsors and Collaborators
Samsung Medical Center
Investigators
| Principal Investigator: | Hyeon-Cheol Gwon, MD, PhD | Samsung Medical Center |
More Information
No publications provided
| Responsible Party: | Hyeon-Cheol Gwon, Professor, Samsung Medical Center |
| ClinicalTrials.gov Identifier: | NCT00942500 History of Changes |
| Other Study ID Numbers: | 2009-02-007 |
| Study First Received: | July 13, 2009 |
| Last Updated: | October 31, 2012 |
| Health Authority: | South Korea: Institutional Review Board |
Keywords provided by Samsung Medical Center:
|
Post-conditioning ST-elevation myocardial infarction Angioplasty, Transluminal, Percutaneous Coronary |
Additional relevant MeSH terms:
|
Infarction Myocardial Infarction Ischemia Pathologic Processes Necrosis |
Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on June 18, 2013